- Home
- IART vs INVA Comparison
IART vs INVA Comparison
Compare IART & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IART
- INVA
- Stock Information
- Founded
- IART 1989
- INVA 1996
- Country
- IART United States
- INVA United States
- Employees
- IART N/A
- INVA N/A
- Industry
- IART Medical/Dental Instruments
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- IART Health Care
- INVA Health Care
- Exchange
- IART Nasdaq
- INVA Nasdaq
- Market Cap
- IART 1.2B
- INVA 1.3B
- IPO Year
- IART 1995
- INVA 2004
- Fundamental
- Price
- IART $14.20
- INVA $17.41
- Analyst Decision
- IART Hold
- INVA Buy
- Analyst Count
- IART 6
- INVA 5
- Target Price
- IART $16.20
- INVA $35.60
- AVG Volume (30 Days)
- IART 1.1M
- INVA 750.7K
- Earning Date
- IART 11-03-2025
- INVA 11-05-2025
- Dividend Yield
- IART N/A
- INVA N/A
- EPS Growth
- IART N/A
- INVA N/A
- EPS
- IART N/A
- INVA 0.53
- Revenue
- IART $1,621,738,000.00
- INVA $370,229,000.00
- Revenue This Year
- IART $5.74
- INVA $7.98
- Revenue Next Year
- IART $4.35
- INVA $11.60
- P/E Ratio
- IART N/A
- INVA $32.74
- Revenue Growth
- IART 3.53
- INVA 12.02
- 52 Week Low
- IART $11.06
- INVA $16.67
- 52 Week High
- IART $27.13
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- IART 50.03
- INVA 30.87
- Support Level
- IART $14.18
- INVA $17.01
- Resistance Level
- IART $14.97
- INVA $19.12
- Average True Range (ATR)
- IART 0.70
- INVA 0.47
- MACD
- IART 0.00
- INVA -0.16
- Stochastic Oscillator
- IART 69.52
- INVA 15.25
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.